Ronghua Yang Selected Research

Mania (Manias)

12/2015	Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments.
10/2010	Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronghua Yang Research Topics

Disease

36	Neoplasms (Cancer) 10/2023 - 08/2013
18	Migraine Disorders (Migraine) 04/2021 - 11/2015
17	Headache (Headaches) 11/2020 - 01/2009
13	Hypoxia (Hypoxemia) 01/2022 - 04/2011
12	Sleepiness 12/2015 - 01/2009
11	Wounds and Injuries (Trauma) 05/2023 - 06/2015
8	Nausea 01/2020 - 01/2009
6	Melanoma (Melanoma, Malignant) 04/2022 - 01/2020
6	Burns 01/2022 - 01/2013
6	Pain (Aches) 11/2019 - 09/2013
6	Diarrhea 08/2015 - 07/2010
4	Lung Neoplasms (Lung Cancer) 11/2018 - 11/2013
4	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2016 - 01/2010
4	Obstructive Sleep Apnea 02/2014 - 01/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 12/2013
3	Reperfusion Injury 01/2021 - 09/2007
3	Obesity 01/2019 - 09/2007
3	Heart Failure 01/2015 - 03/2008
3	Schizophrenia (Dementia Praecox) 09/2012 - 11/2010
3	Narcolepsy 02/2011 - 01/2009
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2024 - 01/2020
2	Cicatrix (Scar) 01/2024 - 01/2020
2	Keloid 09/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2022
2	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 10/2020
2	Infections 10/2021 - 10/2021
2	Wound Infection (Wound Infections) 10/2021 - 08/2016
2	Vomiting 01/2020 - 01/2019
2	Photophobia (Light Sensitivity) 01/2020 - 01/2019
2	Hyperacusis (Phonophobia) 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 12/2019 - 04/2015
2	Alzheimer Disease (Alzheimer's Disease) 05/2019 - 01/2016
2	Disease Progression 05/2019 - 11/2014
2	Adenocarcinoma of Lung 05/2019 - 12/2018
2	Mania (Manias) 12/2015 - 10/2010
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2015 - 10/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015 - 03/2015
2	Chronic Pain 01/2015 - 08/2014
2	Breakthrough Pain 08/2014 - 09/2013
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2014 - 01/2006

Drug/Important Bio-Agent (IBA)

21	Modafinil (Provigil)FDA Link 12/2015 - 01/2006
18	fremanezumabIBA 04/2021 - 11/2015
17	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2013
11	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 04/2010
11	Calcitonin Gene-Related PeptideIBA 01/2021 - 11/2015
9	MicroRNAs (MicroRNA)IBA 11/2021 - 11/2013
9	Monoclonal AntibodiesIBA 01/2021 - 10/2017
7	Messenger RNA (mRNA)IBA 10/2023 - 12/2013
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2019
5	azoreductaseIBA 03/2021 - 01/2018
4	RNA (Ribonucleic Acid)IBA 12/2024 - 10/2018
4	Metal-Organic FrameworksIBA 10/2021 - 07/2019
4	Oxidoreductases (Dehydrogenase)IBA 07/2021 - 12/2016
4	Peptides (Polypeptides)IBA 07/2017 - 09/2014
4	TabletsIBA 01/2015 - 01/2006
3	CollagenIBA 01/2024 - 01/2013
3	EnzymesIBA 10/2023 - 11/2015
3	Nucleic AcidsIBA 10/2023 - 08/2013
3	Therapeutic UsesIBA 01/2022 - 10/2018
3	Long Noncoding RNAIBA 01/2022 - 05/2019
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 12/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2021 - 10/2018
3	Caveolin 1IBA 01/2020 - 01/2019
3	GoldIBA 07/2017 - 03/2015
3	Hydrocodone (Dihydrocodeinone)FDA LinkGeneric 03/2016 - 01/2015
3	Antipsychotic Agents (Antipsychotics)IBA 11/2015 - 03/2012
3	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2015 - 11/2010
3	Opioid Analgesics (Opioids)IBA 01/2015 - 09/2013
3	LeptinIBA 04/2011 - 09/2007
2	S100A12 ProteinIBA 12/2024 - 01/2021
2	HydrogelsIBA 01/2024 - 01/2020
2	AntioxidantsIBA 01/2024 - 11/2022
2	Antisense OligonucleotidesIBA 10/2023 - 10/2018
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 12/2015
2	Dendrimers (Dendrons)IBA 10/2022 - 03/2021
2	CateninsIBA 01/2022 - 06/2015
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 10/2021 - 01/2019
2	tetra(4-N-methylpyridyl)porphineIBA 03/2021 - 10/2018
2	MicellesIBA 01/2021 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2020
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 02/2014
2	Coloring Agents (Dyes)IBA 01/2021 - 07/2017
2	NeuropeptidesIBA 11/2019 - 01/2019
2	Oxygen (Dioxygen)IBA 07/2019 - 10/2018
2	Phosphotransferases (Kinase)IBA 11/2018 - 09/2007
2	azobenzeneIBA 10/2018 - 01/2018
2	SilverIBA 11/2015 - 03/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2015 - 03/2015
2	Analgesics (Analgesic Drugs)IBA 01/2015 - 09/2013
2	Oxycodone (Oxycontin)FDA LinkGeneric 08/2014 - 09/2013
2	Fentanyl (Sublimaze)FDA LinkGeneric 08/2014 - 09/2013

Therapy/Procedure

24	Therapeutics 01/2024 - 11/2010
4	Drug Therapy (Chemotherapy) 10/2023 - 04/2015
3	Immunotherapy 04/2022 - 01/2021
3	Photochemotherapy (Photodynamic Therapy) 03/2021 - 10/2018
3	Subcutaneous Injections 01/2020 - 11/2015
3	Continuous Positive Airway Pressure 02/2014 - 01/2010
2	Duration of Therapy 01/2023 - 10/2010
2	Precision Medicine 10/2021 - 03/2015
2	Cardiopulmonary Resuscitation (CPR) 01/2019 - 03/2017